Dr. Kelley Kiningham, assistant dean of student affairs and associate professor in the Pharmaceutical, Social and Administrative Sciences Department, coauthored an article accepted for publication in Cancer Research. The article, “KEAP1 is a Redox Sensitive Target That Arbitrates the Opposing Radiosensitive Effects of Parthenolide in Normal and Cancer Cells” identifies a mechanism by which differences in cellular redox status can be targeted to kill tumor cells, while protective of normal tissue when radiation is used as a therapeutic. Kiningham states that finding pharmacological approaches to protect normal tissue during treatment of patients with cancer is important to reduce side effects and improve compliance.